Pendopharm gets Health Canada approval for hepatitis C drug Ibavyr
The drug is approved for use in combination with other agents, and will enable some patients to receive an all-oral therapy (without interferon injections), which represents a novel
The drug is approved for use in combination with other agents, and will enable some patients to receive an all-oral therapy (without interferon injections), which represents a novel
The sBLA for Avastin plus chemotherapy (paclitaxel and cisplatin or paclitaxel and topotecan) is based on data from the phase III GOG-0240 trial with an FDA action date
Discovered by Otsuka, the new investigational psychotropic compound brexpiprazole is being co-developed with Lundbeck. The NDA for brexpiprazole is supported by seven completed clinical Phase II or III
Albuterol MDPI is also indicated for the prevention of exercise-induced bronchospasm (EIB) in patients 12 years of age and older. Teva senior vice president of Global Respiratory Research
The study is designed to assess the safety and anti-pruritic efficacy of Nalbuphine ER tablets in about 360 hemodialysis patients to be enrolled in the US and Europe.
As part of the deal, GSK secured a license to use Codexis’ proprietary CodeEvolver protein engineering platform technology in the field of human healthcare. The license enables the
According to the company, Rasuvo will be available in ten dosage strengths, ranging from 7.5mg to 30mg in 2.5mg increments and will be launched in the US. The
As part of the deal, Abbott will carve out the assets and transfer them to a new public company, New Mylan, organised in the Netherlands. After transfer of
The Phase III trial met its primary endpoint and showed that the combination therapy helped these patients live significantly longer without their disease worsening (progression-free survival; PFS) compared
The results show overall efficacy against symptomatic dengue of 56.5% in children aged two to 14 years old after a three-dose vaccination schedule. A total of 10,275 children